舌下免疫治疗对儿童过敏性鼻炎合并过敏性结膜炎的疗效探讨
Efficacy of Sublingual Immunotherapy in Children with Allergic Rhinitis Complicated with Allergic Conjunctivitis
摘要: 目的:探讨舌下免疫治疗对儿童过敏性鼻炎合并过敏性结膜炎的临床疗效。方法:选取2024年10月~2025年5月就诊安徽医科大学第二附属医院的过敏性鼻炎合并过敏性结膜炎的4~12岁患儿110例,按随机数字表法分为对照组和研究组,各55例,给予对照组常规药物治疗,研究组在对照组用药基础上给予舌下含服粉尘螨滴剂治疗。比较两组患儿的疗效、鼻眼部症状评分、视觉模拟评分法(VAS)评分、不良反应。结果:治疗组治疗的总有效率高于对照组,差异有统计学意义(P < 0.05)。治疗后,研究组鼻眼部症状评分、视觉模拟评分法(VAS)评分均低于对照组,差异有统计学意义(P < 0.05)。研究组仅1例出现轻微口腔黏膜瘙痒,未予特殊处理,随疗程自行缓解,无严重不良反应发生;对照组未出现不良反应。结论:舌下免疫治疗能显著改善鼻炎和结膜炎症状评分,提高患者生活质量。
Abstract: Objective: To explore the clinical efficacy of sublingual immunotherapy (SLIT) in children with allergic rhinitis complicated by allergic conjunctivitis. Methods: A total of 110 children with allergic rhinitis complicated by allergic conjunctivitis who were admitted to the Second Affiliated Hospital of Anhui Medical University from October 2024 to May 2025 were selected. They were divided into a control group and a study group with 55 cases in each group according to the random number table method. The control group was given conventional drug treatment, and the study group was given sublingual administration of Dermatophagoides farinae drops on the basis of the medication in the control group. The efficacy, nasal and ocular symptom scores, visual analog scale (VAS) scores, and adverse reactions were compared between the two groups. Results: The total effective rate of the study group was higher than that of the control group, with a statistically significant difference (P < 0.05). After treatment, the nasal and ocular symptom scores and VAS scores of the study group were lower than those of the control group, with statistically significant differences (P < 0.05). Only 1 case in the study group had mild oral mucosal itching, which was not given special treatment and relieved spontaneously with the course of treatment, and no serious adverse reactions such as anaphylactic shock occurred; no adverse reactions occurred in the control group. Conclusion: Sublingual immunotherapy can significantly improve the scores of rhinitis and conjunctivitis symptoms, and improve the quality of life of patients.
文章引用:何英磊, 杨见明. 舌下免疫治疗对儿童过敏性鼻炎合并过敏性结膜炎的疗效探讨[J]. 临床医学进展, 2026, 16(2): 879-885. https://doi.org/10.12677/acm.2026.162463

参考文献

[1] 薛建荣, 马敬, 蒋星, 等. 苏南地区儿童变应性鼻结膜炎临床研究[J]. 山东大学耳鼻喉眼学报, 2017, 31(3): 41-46.
[2] 付艳乔, 李国义. 糠酸莫米松鼻喷雾剂与孟鲁司特钠联合治疗儿童季节性变应性鼻炎的临床疗效分析[J]. 湖南师范大学学报: 医学版, 2017, 14(4): 94-97.
[3] Wang, C., Bao, Y., Chen, J., Chen, X., Cheng, L., Guo, Y.S., et al. (2022) Chinese Guideline on Allergen Immunotherapy for Allergic Rhinitis: The 2022 Update. Allergy, Asthma & Immunology Research, 14, 604-652. [Google Scholar] [CrossRef] [PubMed]
[4] 赵堪兴, 杨培增. 眼科学[M]. 第9版. 北京: 人民卫生出版社, 2018: 186-190.
[5] 王辰, 詹庆元. 呼吸与危重症医学[M]. 第2版. 北京: 人民卫生出版社, 2021: 1256-1263.
[6] Liu, Y., Zhang, L., Wang, L., et al. (2022) Prevalence of Allergic Rhinitis and Conjunctivitis in Children Aged 3-12 Years in Urban Areas of China. Allergy, Asthma & Clinical Immunology, 18, Article 65.
[7] 李明华, 殷凯生, 沈华浩. 哮喘病学[M]. 第4版. 北京: 人民卫生出版社, 2020: 789-796.
[8] 中华医学会耳鼻咽喉头颈外科学分会鼻科学组. 变应性鼻炎诊断和治疗指南(202年版) [J]. 中华耳鼻咽喉头颈外科杂志, 2022, 57(2): 81-142.
[9] 中华医学会变态反应学分会免疫治疗学组. 舌下免疫治疗专家共识(2020版) [J]. 中华变态反应和临床免疫杂志, 2020, 14(4): 265-272.
[10] 陈育智. 儿童支气管哮喘诊断与防治指南(2020版)解读[J]. 中华实用儿科临床杂志, 2020, 35(23): 1761-1764.
[11] 张宏誉. 临床变态反应学[M]. 第3版. 北京: 人民卫生出版社, 2019: 458-465.
[12] Frati, F., Ridolo, E., Fuiano, N., Barberi, S., Dell’Albani, I., Landi, M., et al. (2014) Safety of Sublingual Immunotherapy in Children. Expert Opinion on Drug Safety, 13, 947-953. [Google Scholar] [CrossRef] [PubMed]
[13] 段传新, 田滢, 张飞, 等. 舌下含服免疫治疗与皮下注射免疫治疗对儿童变应性鼻炎的疗效分析[J]. 临床耳鼻咽喉头颈外科杂志, 2016, 30(17): 1354-1357.
[14] Leung, M.S.T., O’Neill, P., Dennett, E., Kew, K.M. and Fortescue, R. (2021) The Safety and Efficacy of SLIT Compared to Placebo or Standard Care for Children with Asthma. Paediatric Respiratory Reviews, 37, 54-56. [Google Scholar] [CrossRef] [PubMed]